Interpace Diagnostics Group's market cap is currently $5.55M. The company's EPS TTM is $1.069; its P/E ratio is 1.17; Interpace Diagnostics Group is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 40.21M	$ 31.84M	$ 41.31M	$ 32.40M	$ 24.08M
Gross Profit	$ 23.90M	$ 18.23M	$ 17.95M	$ 10.72M	$ 8.19M
Operating Income	$ 2.80M	$ -3.84M	$ -11.74M	$ -26.55M	$ -23.93M
EBITDA	$ 3.84M	$ -2.27M	$ -1.33M	$ -20.10M	$ -21.72M
Net Income	$ 802.00K	$ -5.87M	$ -14.75M	$ -26.20M	$ -26.64M
Balance Sheet
Cash & Short-Term Investments	$ 3.50M	$ 4.83M	$ 3.31M	$ 2.77M	$ 2.32M
Total Assets	$ 13.02M	$ 15.98M	$ 38.43M	$ 45.68M	$ 69.05M
Total Debt	$ 11.19M	$ 16.09M	$ 13.72M	$ 4.74M	$ 7.10M
Net Debt	$ 7.69M	$ 11.26M	$ 10.40M	$ 1.97M	$ 4.78M
Total Liabilities	$ 28.16M	$ 79.05M	$ 80.84M	$ 74.76M	$ 56.02M
Stockholders' Equity	$ -15.14M	$ -63.07M	$ -42.42M	$ -29.08M	$ 13.03M
Cash Flow
Free Cash Flow	$ 3.32M	$ -8.01M	$ -9.07M	$ -16.15M	$ -19.09M
Operating Cash Flow	$ 3.79M	$ -7.69M	$ -8.72M	$ -14.58M	$ -18.96M
Investing Cash Flow	$ -87.00K	$ 6.21M	$ -315.00K	$ -1.57M	$ -13.95M
Financing Cash Flow	$ -5.03M	$ 3.00M	$ 8.98M	$ 16.61M	$ 29.16M

Currency in USD

Interpace Diagnostics Group Earnings and Revenue History

Income Statement >

Interpace Diagnostics Group Debt to Assets

Balance Sheet >

Interpace Diagnostics Group Cash Flow

Cash Flow >

Interpace Diagnostics Group Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing